Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M181,349Revenue $M51,584Net Margin (%)20.7Z-Score2.5
Enterprise Value $M185,477EPS $3.2Operating Margin %26.8F-Score6
P/E(ttm))18.0Cash Flow Per Share $3.5Pre-tax Margin (%)26.8Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %3.2Quick Ratio2.4Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %8.5Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %2.3ROA % (ttm)6.0Higher Current Ratio y-yY
Dividend Yield %3.6Insider Buy (3m)0ROE % (ttm)13.4Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M6,341ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 28.6-5%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 28.6-5%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 28.6-5%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 28.6-5%Add 250.56%393,008
PFEMichael Price 2014-06-30 Reduce-0.97%$29.02 - $32.4
($30.05)
$ 28.6-5%Reduce -69.14%107,100
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 28.6-5%Reduce -31.07%6,363,006
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 28.6-5%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 28.6-5%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 28.6-5%Sold Out0
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 28.6-5%Reduce -33.68%128,800
PFEIrving Kahn 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 28.6-9%Add 11.22%2,112,819
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 28.6-9%Add 356.54%1,014,808
PFEJohn Hussman 2014-03-31 Buy 0.04%$29.66 - $32.75
($31.36)
$ 28.6-9%New holding, 17000 sh.17,000
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 28.6-9%Reduce -40.13%7,276,622
PFENWQ Managers 2014-03-31 Reduce-0.39%$29.66 - $32.75
($31.39)
$ 28.6-9%Reduce -13.6%9,231,207
PFEJean-Marie Eveillard 2014-03-31 Reduce-0.19%$29.66 - $32.75
($31.39)
$ 28.6-9%Reduce -22.77%7,866,473
PFERobert Bruce 2013-12-31 Add0.17%$28.24 - $32.2
($30.7)
$ 28.6-7%Add 4.63%452,000
PFEJean-Marie Eveillard 2013-12-31 Add0.16%$28.24 - $32.2
($30.7)
$ 28.6-7%Add 23.07%10,186,005
PFEJoel Greenblatt 2013-12-31 Add0.11%$28.24 - $32.2
($30.7)
$ 28.6-7%Add 241.71%222,280
PFERonald Muhlenkamp 2013-12-31 Add0.05%$28.24 - $32.2
($30.7)
$ 28.6-7%Add 29.15%45,129
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:


News about PFE:

Articles On GuruFocus.com
Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU Oct 20 2014 
10 Stocks With The Highest Share Buyback Volume In 2014 Oct 03 2014 
A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
I Am Sure This Pharma-Company Suits Your Portfolio Aug 28 2014 
Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG Aug 18 2014 
A Strong Candidate for Investor´s Portfolios Aug 12 2014 
Legendary Investor Irving Kahn's Top Five Stocks Aug 08 2014 

More From Our Partners
5-Star And Dow Analysts Give 9% Edge To Lowest-Priced High-Yield Stocks Oct 22 2014 - SEEKINGALPHA

More From Other Websites
Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes Oct 24 2014
Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes Oct 24 2014
Pfizer's $11 bln buyback plan deflates AstraZeneca bid hopes Oct 24 2014
Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend Oct 23 2014
Pfizer approves $US11bn repurchase plan Oct 23 2014
Pfizer shares rise on $11B buyback program Oct 23 2014
[$$] Pfizer Plans $11 Billion Stock Buyback Oct 23 2014
[video] U.S. Earnings Are `Going to Accelerate,' Cote Says Oct 23 2014
Pfizer Announces Eye-Popping $11 Billion Share Buyback Plan Oct 23 2014
Pfizer board authorizes $11 billion share repurchase Oct 23 2014
Pfizer board authorizes $11 billion share repurchase Oct 23 2014
Pfizer board authorizes $11 billion share repurchase Oct 23 2014
Pfizer Announces It Will Buy Back $11 Billion in Shares Oct 23 2014
Pfizer approves $11B stock repurchase plan Oct 23 2014
Pfizer approves $11B stock repurchase plan Oct 23 2014
Pfizer shares rise after new $11 billion share buyback program Oct 23 2014
Taking Stock: Winners and Losers, Stock of the Day Oct 23 2014
Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend Oct 23 2014
U.S. court upholds patents on Pfizer's cancer drug Oct 23 2014
Pfizer Wins SUTENT® Patent Case In Delaware District Court Oct 23 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 4 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK